Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 132, Issue 11
September 13 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

MYELOID NEOPLASIA
CHIPing out PPM1D-mutant hematopoiesis
Thomas Kindler
View Articletitled, CHIPing out PPM1D-mutant hematopoiesis
PLATELETS AND THROMBOPOIESIS
The incomparable platelet: holy alveoli!
Mark R. Looney
View Articletitled, The incomparable platelet: holy alveoli!
PLATELETS AND THROMBOPOIESIS
Platelet metabolism meets thrombosis
Yiliang Chen,Roy L. Silverstein
View Articletitled, Platelet metabolism meets thrombosis
TRANSFUSION MEDICINE
Rhesus pieces: genotype matching of RBCs
Jeanne E. Hendrickson,Christopher A. Tormey
View Articletitled, Rhesus pieces: genotype matching of RBCs

PLENARY PAPER

MYELOID NEOPLASIA
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Josephine D. Kahn,Peter G. Miller,Alexander J. Silver,Rob S. Sellar,Shruti Bhatt,Christopher Gibson,Marie McConkey,Dylan Adams,Brenton Mar,Philipp Mertins,Shaunt Fereshetian,Karsten Krug,Haoling Zhu,Anthony Letai,Steven A. Carr,John Doench,Siddhartha Jaiswal,Benjamin L. Ebert
View Articletitled, <em>PPM1D</em>-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Supplemental data

PERSPECTIVE

Differentiation-based model of hematopoietic stem cell functions and lineage pathways
Thomas Höfer,Hans-Reimer Rodewald
View Articletitled, Differentiation-based model of hematopoietic stem cell functions and lineage pathways

HOW I TREAT

How I treat the young patient with multiple myeloma
Clinical Trials & Observations
Sara Gandolfi,Claudia Paba Prada,Paul G. Richardson
View Articletitled, How I treat the young patient with multiple myeloma

CLINICAL TRIALS AND OBSERVATIONS

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
Clinical Trials & Observations
Amir T. Fathi,Harry P. Erba,Jeffrey E. Lancet,Eytan M. Stein,Farhad Ravandi,Stefan Faderl,Roland B. Walter,Anjali S. Advani,Daniel J. DeAngelo,Tibor J. Kovacsovics,Anand Jillella,Dale Bixby,Moshe Y. Levy,Megan M. O’Meara,Phoenix A. Ho,Jenna Voellinger,Anthony S. Stein
View Articletitled, A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
Yasushi Akahori,Linan Wang,Motohiro Yoneyama,Naohiro Seo,Satoshi Okumura,Yoshihiro Miyahara,Yasunori Amaishi,Sachiko Okamoto,Junichi Mineno,Hiroaki Ikeda,Takehiro Maki,Hiroshi Fujiwara,Yoshiki Akatsuka,Takuma Kato,Hiroshi Shiku
View Articletitled, Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
Supplemental data

LYMPHOID NEOPLASIA

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Tammy Linlin Song,Maarja-Liisa Nairismägi,Yurike Laurensia,Jing-Quan Lim,Jing Tan,Zhi-Mei Li,Wan-Lu Pang,Atish Kizhakeyil,Giovani-Claresta Wijaya,Da-Chuan Huang,Sanjanaa Nagarajan,Burton Kuan-Hui Chia,Daryl Cheah,Yan-Hui Liu,Fen Zhang,Hui-Lan Rao,Tiffany Tang,Esther Kam-Yin Wong,Jin-Xin Bei,Jabed Iqbal,Nicholas-Francis Grigoropoulos,Siok-Bian Ng,Wee-Joo Chng,Bin-Tean Teh,Soo-Yong Tan,Navin Kumar Verma,Hao Fan,Soon-Thye Lim,Choon-Kiat Ong
View Articletitled, Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Supplemental data
Disparities in survival by insurance status in follicular lymphoma
Clinical Trials & Observations
Jordan S. Goldstein,Loretta J. Nastoupil,Xuesong Han,Ahmedin Jemal,Elizabeth Ward,Christopher R. Flowers
View Articletitled, Disparities in survival by insurance status in follicular lymphoma
Supplemental data

PLATELETS AND THROMBOPOIESIS

Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction
Nagaharu Tsukiji,Osamu Inoue,Mitsuru Morimoto,Norifumi Tatsumi,Hiroaki Nagatomo,Koji Ueta,Toshiaki Shirai,Tomoyuki Sasaki,Shimon Otake,Shogo Tamura,Toshiaki Tachibana,Masataka Okabe,Masanori Hirashima,Yukio Ozaki,Katsue Suzuki-Inoue
View Articletitled, Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction
Supplemental data
AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation
Sophie Lepropre,Shakeel Kautbally,Marie Octave,Audrey Ginion,Marie-Blanche Onselaer,Gregory R. Steinberg,Bruce E. Kemp,Alexandre Hego,Odile Wéra,Sanne Brouns,Frauke Swieringa,Martin Giera,Victor M. Darley-Usmar,Jérôme Ambroise,Bruno Guigas,Johan Heemskerk,Luc Bertrand,Cécile Oury,Christophe Beauloye,Sandrine Horman
View Articletitled, AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation
Supplemental data

THROMBOSIS AND HEMOSTASIS

A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation
Brief Report
Vincent Muczynski,Caterina Casari,François Moreau,Gabriel Aymé,Charlotte Kawecki,Paulette Legendre,Valerie Proulle,Olivier D. Christophe,Cécile V. Denis,Peter J. Lenting
View Articletitled, A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation
Supplemental data

TRANSFUSION MEDICINE

RH genotype matching for transfusion support in sickle cell disease
Stella T. Chou,Perry Evans,Sunitha Vege,Sarita L. Coleman,David F. Friedman,Margaret Keller,Connie M. Westhoff
View Articletitled, <em>RH</em> genotype matching for transfusion support in sickle cell disease
Supplemental data

LETTERS TO BLOOD

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol
Clinical Trials & Observations
Lianna J. Marks,Kathleen M. McCarten,Qinglin Pei,Debra L. Friedman,Cindy L. Schwartz,Kara M. Kelly
View Articletitled, Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol
A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing
Claudia Wehr,Katja Grotius,Silvia Casadei,Dorothee Bleckmann,Sebastian F. N. Bode,Björn C. Frye,Maximilian Seidl,Suleyman Gulsuner,Mary-Claire King,Mary-Beth Percival,Colin C. Pritchard,Tom Walsh,David Wu,Siobán Keel,Ulrich Salzer
View Articletitled, A novel disease-causing synonymous exonic mutation in <em>GATA2</em> affecting RNA splicing
Supplemental data

BLOOD WORK

Hairy cell leukemia in a child?!
Madeleen Bosma,Marije Bartels
View Articletitled, Hairy cell leukemia in a child?!
All Issues

Advertisement

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement